Evidence map›Paper›PMID 39697981›Full record

ArticleUpsala journal of medical sciences2024

The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease.

Per Wändell, Tobias Feldreich, Anders Larsson, Philip A Kalra, Johan Ärnlöv, Toralph Ruge, Axel C Carlsson

Abstract read
In one paragraph

Article in Upsala journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Per WändellDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Tobias FeldreichSchool of Health and Welfare, Dalarna University, Falun, Sweden.
Anders LarssonDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Philip A KalraDepartment of Renal medicine, Salford Royal, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Johan ÄrnlövDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Toralph RugeDepartment of Emergency and Internal Medicine, Skånes University Hospital, Malmö, Sweden.
Axel C CarlssonDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Higher circulating levels of tumor necrosis factor (TNF) alpha receptors 1 (TNFR1) and 2 (TNFR2) are associated with increased long-term mortality and impaired kidney function. Aim: To study associations between levels of TNFR1 and TNFR2 and all-cause mortality as well as estimated glomerular filtration rate (eGFR) decline. Population and methods: Patients with chronic kidney disease (CKD) stages 3-5 in the Salford Kidney Study were included. Associations between one standard deviation increase in Results: Univariate models showed significant associations between TNFR1 Conclusions: TNFR2 was associated with mortality, but TNFR1 was not, although showing a borderline value. Neither TNFR1 nor TNFR2 predicted decline in kidney function. TNFR1 and TNFR2 portray interesting aspects in patients with CKD, but the clinical utility seems limited.

Indexed as

Glomerular Filtration RateReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRenal Insufficiency, ChronicAdultAgedCreatinineFemaleHumansKidneyMaleMiddle AgedProportional Hazards ModelsCreatinineReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITNFRSF1A protein, humanTNFRSF1B protein, humancardiovascular diseasescardiovascular risk factorsChronic kidney diseasedecline in kidney functionmortalitySoluble Tumor Necrosis Factor Receptor (TNFR)

Identifiers

PMID39697981
PMCPMC11653433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.